Evidence map›Paper›PMID 29030231›Full record

ArticleBone2018

ALS-associated mutation SOD1

Huan Wang, Jianxun Yi, Xuejun Li, Yajuan Xiao, Kamal Dhakal, Jingsong Zhou

Open access · greenAbstract read
In one paragraph

Article in Bone, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Antibody-Based PET Imaging of Misfolded Superoxide Dismutase 1 in an Amyotrophic Lateral Sclerosis Mouse Model.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  6. Mitochondria in health, disease, and aging.Physiological reviews · 2023
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. BMP/TGF-β signaling as a modulator of neurodegeneration in ALS.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Article
  12. Article
  13. Article
  14. Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases:International journal of molecular sciences · 2021
    Review
  15. Progressive Mitochondrial SOD1International journal of molecular sciences · 2021
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Huan WangKansas City University of Medicine and Bioscience, Kansas City, MO, USA.
Jianxun YiKansas City University of Medicine and Bioscience, Kansas City, MO, USA.
Xuejun LiKansas City University of Medicine and Bioscience, Kansas City, MO, USA.
Yajuan XiaoKansas City University of Medicine and Bioscience, Kansas City, MO, USA.
Kamal DhakalKansas City University of Medicine and Bioscience, Kansas City, MO, USA.
Jingsong ZhouKansas City University of Medicine and Bioscience, Kansas City, MO, USA. Electronic address: jzhou@kcumb.edu.
Kansas City University · US

Funding

Ca Signaling in Progression of Amyotrophic Lateral Sclerosis in Skeletal MuscleR01AR057404 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI ZHOU, JINGSONG · 2010 to 2014
$1.6M
NIAMS NIH HHS R01 AR057404
6 · The paper itself

Abstract

While the death of motor neuron is a pathological hallmark of amyotrophic lateral sclerosis (ALS), defects in other cell types or organs may also actively contribute to ALS disease progression. ALS patients experience progressive skeletal muscle wasting that may not only exacerbate neuronal degeneration, but likely has a significant impact on bone function. In our previous published study, we have discovered severe bone loss in an ALS mouse model with overexpression of ALS-associated mutation SOD1

Indexed as

Amyotrophic Lateral SclerosisAnimalsDisease Models, AnimalFluorescent Antibody TechniqueImmunoblottingMiceMice, TransgenicMitochondrial DynamicsMotor NeuronsMutationOsteocytesSuperoxide Dismutase-1Superoxide Dismutase-1Amyotrophic lateral sclerosis (ALS)MitochondriaMitochondrial dynamicsOsteocytes

Identifiers

PMID29030231
PMCPMC5718158
OpenAlexW2763635610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.